Prognostic significance of IgM anti-HD during interferon therapy.
S. Giacomo Hospital, Rome, Italy.
G
G
Marinucci
G
G
Hassan
C
C
Di Giacomo
A
A
Dato
A
A
Barlattani
F
F
Costa
D000293:Adolescent; D000328:Adult; D005260:Female; D006508:Hepatitis Antibodies / Q000097:blood; D003699:Hepatitis D / Q000276:immunology* / Q000628:therapy*; D003698:Hepatitis Delta Virus / Q000276:immunology* / Q000502:physiology; D006801:Humans; D007075:Immunoglobulin M / Q000097:blood*; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008297:Male; D011379:Prognosis; D012367:RNA, Viral / Q000097:blood; D011994:Recombinant Proteins; D013997:Time Factors; D014766:Viremia / Q000628:therapy; D014779:Virus Replication
D006508:Hepatitis Antibodies; D007075:Immunoglobulin M; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D012367:RNA, Viral; D011994:Recombinant Proteins